A new antiviral drug development center will be led by Scripps Research, one of nine National Institute of Allergy and Infectious Diseases-sponsored Antiviral Drug Discovery Centers for Pathogens of Pandemic Concern.
A new antiviral drug development center will be led by Scripps Research, one of nine National Institute of Allergy and Infectious Diseases-sponsored Antiviral Drug Discovery Centers for Pathogens of Pandemic Concern.
This website, like most media sites, uses small files called cookies to anonymously customize the advertising that you see. Learn more about how we use cookies in our cookie policy.